CIM Investment Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

CIM Investment Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-734	Closed	-$232K	–	297
2023 Q4	$232K	Buy	+734	New	+$143K	0.07%	244

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

CIM Investment Management's KRTX Position: Q1 2024 in Review

CIM Investment Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 734 shares — an estimated $232K sold.

CIM Investment Management first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $232K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

CIM Investment Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
CIM Investment Management sold 734 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $232K.
CIM Investment Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
CIM Investment Management's Karuna Therapeutics, Inc. Common Stock position peaked at $232K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on CIM Investment Management's 13F filing for Q1 2024, filed 7 May 2024.